Molecular Testing for MRSA and C. diff.: Using New Tools to Identify and Reduce HAIs
15 Nov 2012

For both economic and regulatory reasons, hospitals and other healthcare facilities are stepping up efforts to decrease healthcare-associated infection (HAI) rates. Clinical labs can be helpful in these initiatives, particularly in identifying methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile (C. diff.) infections. This webinar discusses the new technologies that detect these pathogens more quickly and accurately than ever before, and how labs are incorporating them into their testing strategies and surveillance programs.

AACC



Show    per page
1 of 9 Page     1 2 3  ... Next 
Reprogramming of Somatic Cells to Pluripotency Under Low O2 Conditions20 Nov 2014Read
Issues of Color in Histology in Medicine20 Nov 2014Read
Instrument performance verification in laser diffraction11 Nov 2014Read
From Daltons to Megadaltons on a Single Mass Spectrometry Platform: UHR-qTOF for Biopharmaceuticals Analysis11 Nov 2014Read
Powering power plants with online particle size analysis11 Nov 2014Read
How to characterize and optimize inkjet inks - Part 111 Nov 2014Read
How to characterize and optimize inkjet inks Part 211 Nov 2014Read
Pharmaceuticals - When size is not enough11 Nov 2014Read
Exploring the role of SEC-MALS in protein and polymer characterization11 Nov 2014Read
Clinical Research of Complex Congenital Brain Malformations by Combined Neuroimaging and Massively Parallel Sequencing Using the TruSight One Sequencing Panel6 Nov 2014Read